Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain.
Miranda-Bautista J, Verdejo C, Díaz-Redondo A, Bretón I, Bellón JM, Pérez-Valderas MD, Caballero-Marcos A, de Dios-Lascuevas M, González-Río E, García-Sánchez C, Marín-Jiménez I, Bañares R, Menchén L. Miranda-Bautista J, et al. Among authors: bellon jm. Therap Adv Gastroenterol. 2019 Jul 31;12:1756284819862152. doi: 10.1177/1756284819862152. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31391867 Free PMC article.
Persistence of Clinically Significant Portal Hypertension After Eradication of Hepatitis C Virus in Patients With Advanced Cirrhosis.
Díez C, Berenguer J, Ibañez-Samaniego L, Llop E, Pérez-Latorre L, Catalina MV, Hontañón V, Jiménez-Sousa MA, Aldámiz-Echevarría T, Martínez J, Calleja JL, Albillos A, Bellón JM, Resino S, González-García J, Bañares R. Díez C, et al. Among authors: bellon jm. Clin Infect Dis. 2020 Dec 17;71(10):2726-2729. doi: 10.1093/cid/ciaa502. Clin Infect Dis. 2020. PMID: 32386053
Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients.
Salgüero S, Rojo D, Berenguer J, González-García J, Fernández-Rodríguez A, Brochado-Kith O, Díez C, Hontañon V, Virseda-Berdices A, Martínez J, Ibañez-Samaniego L, Llop-Herrera E, Barbas C, Resino S, Jiménez-Sousa MA; Escorial Study Group. Salgüero S, et al. Liver Int. 2020 Sep;40(9):2215-2227. doi: 10.1111/liv.14580. Epub 2020 Jul 7. Liver Int. 2020. PMID: 32593189
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.
Berenguer J, Aldámiz-Echevarría T, Hontañón V, Fanciulli C, Quereda C, Busca C, Domínguez L, Hernández C, Vergas J, Gaspar G, García-Fraile LJ, Díez C, De Miguel M, Bellón JM, Bañares R, González-García J. Berenguer J, et al. Among authors: bellon jm. Hepatology. 2024 Mar 7. doi: 10.1097/HEP.0000000000000838. Online ahead of print. Hepatology. 2024. PMID: 38452004
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score.
Berenguer J, Borobia AM, Ryan P, Rodríguez-Baño J, Bellón JM, Jarrín I, Carratalà J, Pachón J, Carcas AJ, Yllescas M, Arribas JR; COVID-19@Spain and COVID@HULP Study Groups. Berenguer J, et al. Among authors: bellon jm. Thorax. 2021 Sep;76(9):920-929. doi: 10.1136/thoraxjnl-2020-216001. Epub 2021 Feb 25. Thorax. 2021. PMID: 33632764 Free PMC article.
[Prevalence of resistance to antiretroviral drugs in Spain].
Larrú Martínez B, de José MI, Bellón JM, Gurbindo MD, León JA, Ciria L, Ramos JT, Mellado MJ, Pocheville I, Jiménez JL, Muñoz-Fernández M. Larrú Martínez B, et al. Among authors: bellon jm. An Pediatr (Barc). 2007 Aug;67(2):104-8. doi: 10.1016/s1695-4033(07)70569-6. An Pediatr (Barc). 2007. PMID: 17692254 Free article. Spanish.
National registry of hemoglobinopathies in Spain (REPHem).
Cela E, Bellón JM, de la Cruz M, Beléndez C, Berrueco R, Ruiz A, Elorza I, Díaz de Heredia C, Cervera A, Vallés G, Salinas JA, Coll MT, Bermúdez M, Prudencio M, Argilés B, Vecilla C; SEHOP-Hemoglobinopathies Study Group (Sociedad Española de Hematología y Oncología Pediátricas). Cela E, et al. Among authors: bellon jm. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26322. Epub 2016 Nov 2. Pediatr Blood Cancer. 2017. PMID: 27804209
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.
Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I; GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation. Martínez-Laperche C, et al. Among authors: bellon jm. Blood Adv. 2018 Jul 24;2(14):1719-1737. doi: 10.1182/bloodadvances.2017011502. Blood Adv. 2018. PMID: 30030270 Free PMC article. Clinical Trial.
Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients.
Carrero A, Berenguer J, Hontañón V, Guardiola JM, Navarro J, von Wichmann MA, Téllez MJ, Quereda C, Santos I, Sanz J, Galindo MJ, Hernández-Quero J, Jiménez-Sousa MA, Pérez-Latorre L, Bellón JM, Resino S, Esteban H, Martínez E, González-García J; Grupo de Estudio del Sida (GESIDA) 3603B Study Group. Carrero A, et al. Among authors: bellon jm. Clin Infect Dis. 2021 Oct 5;73(7):e2026-e2033. doi: 10.1093/cid/ciaa1396. Clin Infect Dis. 2021. PMID: 32930720
369 results